Form 4 for HUM Humana
Accepted 2026-05-05 14:27:17 ET · period of report 2026-05-01 · accession 0002006065-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-05-05 14:27 | 2026-05-01 | HUM | Rechtin James A. | Pres, CEO | A - Grant | $0.00 | +35.6K | 63.9K | +126% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Humana Common | 2026-05-01 | A | A | 35,633 | $0.00 | 63,938 | I See Footnote | — | — | (F6) Includes 49,687 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plans. (F1) All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees. |